These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11394640)

  • 1. Effects of endomorphin-1 on open-field behavior and on the hypothalamic-pituitary-adrenal system.
    Bujdosó E; Jászberényi M; Tömböly C; Tóth G; Telegdy G
    Endocrine; 2001 Mar; 14(2):221-4. PubMed ID: 11394640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and neuroendocrine actions of endomorphin-2.
    Bujdosó E; Jászberényi M; Tömböly C; Tóth G; Telegdy G
    Peptides; 2001 Sep; 22(9):1459-63. PubMed ID: 11514029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of dopamine and nitric oxide in the endocrine and behavioural action of endomorphin-1.
    Bujdosó E; Jászberényi M; Gardi J; Földesi I; Telegdy G
    Neuroscience; 2003; 120(1):261-8. PubMed ID: 12849758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine, behavioral and autonomic effects of neuropeptide AF.
    Jászberényi M; Bagosi Z; Thurzó B; Földesi I; Szabó G; Telegdy G
    Horm Behav; 2009 Jun; 56(1):24-34. PubMed ID: 19269292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-3 stimulates the hypothalamic-pituitary-adrenal axis.
    Hirai M; Miyabo S; Ooya E; Miyanaga K; Aoyagi N; Kimura K; Kishida S; Nakai T
    Life Sci; 1991; 48(24):2359-63. PubMed ID: 1646364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic actions of neuromedin U.
    Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; Ghatei MA; Bloom SR
    Endocrinology; 2002 Nov; 143(11):4227-34. PubMed ID: 12399416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin.
    Jászberényi M; Bujdosó E; Bagosi Z; Telegdy G
    Horm Behav; 2006 Aug; 50(2):266-73. PubMed ID: 16643913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal activation following endotoxin administration in the developing rat: a CRH-mediated effect.
    Shanks N; Meaney MJ
    J Neuroendocrinol; 1994 Aug; 6(4):375-83. PubMed ID: 7987367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats.
    Jászberényi M; Bagosi Z; Csabafi K; Palotai M; Telegdy G
    Regul Pept; 2014 Jan; 188():46-51. PubMed ID: 24316399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13.
    Jászberényi M; Bujdosó E; Telegdy G
    Neuroscience; 2004; 129(3):811-6. PubMed ID: 15541902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory factor (LIF) and corticotropin-releasing hormone (CRH) gene expression in the mouse.
    Pechnick RN; Kariagina A; Hartvig E; Bresee CJ; Poland RE; Chesnokova VM
    Psychopharmacology (Berl); 2006 Mar; 185(1):76-83. PubMed ID: 16416158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
    Korbonits M; Kaltsas G; Perry LA; Putignano P; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of action of 5-hydroxytryptophan and 5-hydroxytryptamine on the hypothalamo-pituitary-adrenal system in vitro.
    Telegdy G; Kardos M
    Acta Physiol Acad Sci Hung; 1975; 46(3):253-6. PubMed ID: 198221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.
    Bornstein SR; Webster EL; Torpy DJ; Richman SJ; Mitsiades N; Igel M; Lewis DB; Rice KC; Joost HG; Tsokos M; Chrousos GP
    Endocrinology; 1998 Apr; 139(4):1546-55. PubMed ID: 9528933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin.
    Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation.
    Aguilera G; Lightman SL; Kiss A
    Endocrinology; 1993 Jan; 132(1):241-8. PubMed ID: 8380375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.